Lääketietokeskus Koulutus Koulutuskalenteri Nordic Collaboration in Clinical Research

Nordic Collaboration in Clinical Research

Nordic Trial Alliance – Collaboration between Industry and Academy. Excellent opportunities and possibilities for clinical research in the Nordic region.

The Nordic countries are known for good clinical research, high clinical expertise, excellent opportunities to create advanced research infrastructures, and also for well-organized health care systems that encompass entire populations. The Nordic countries are in the forefront in developing and implementing strategies and specific projects that improve the competitiveness of European clinical research.

Conference objectives

The aim of this Nordic Trial Alliance (NTA) conference is to showcase the opportunities, possibilities and advantages that exist in the Nordic region for clinical research. Each country will present strategies and initiatives from the government level, specific projects undertaken at hospitals and universities, and distinctive resources and platforms for clinical research.

Who should attend?

The main audience is researchers, authorities and regulators, ethical committees, politicians, patient organizations, clinical research and development directors and managers from Nordic pharmaceutical companies.

Registration and cancellations

The last official registration date is April 8th. When registering, please inform us which conference day or days you are attending. 

Cancellations can be made at no charge up until 14 days before the conference. Registrations cancelled less than 14 days before the conference will be charged 100 €/conference day (+ VAT 24 %) of the cancellation charges and organization costs. Cancellations should be addressed in writing. 

Exhibition area

We offer organizations an exhibition package for 500 € (+ VAT 24 %) for PIF, LIF and LMI member companies and 700 € (+ VAT 24 %) for non-members. All stands come equipped with a power socket, a table and a place for company's own roll up. The fee also includes a complimentary registration for one company representative, including lunch and refreshments during the conference days.

Please contact koulutus@laaketietokeskus.fi to book an exhibition package at least 14 days before the conference.

Organizers 

  • Nordic Trial Alliance
  • Norden NordFosk
  • PIF – Pharma Industry Finland
  • LMI – The Association of Pharmaceutical Industry in Norway
  • LIF – The research-based pharmaceutical industry in Sweden
  • LIF – The Danish Association of the Pharmaceutical Industry

Hotels closest to the venue

Crowne Plaza Helsinki (Address: Mannerheimintie 50)

Scandic Park Helsinki (Address: Mannerheimintie 46)

Contact information

For further questions about the conference program, please contact Mia Bengtström, mia.bengtstrom@pif.fi.

For further questions about the registration and the arrangements, please contact koulutus@laaketietokeskus.fi or Viktoria Paananen, viktoria.paananen@laaketietokeskus.fi.

Nordic Trial Alliance – Collaboration between Industry and Academy. Excellent opportunities and possibilities for clinical research in the Nordic region.

The Nordic countries are known for good clinical research, high clinical expertise, excellent opportunities to create advanced research infrastructures, and also for well-organized health care systems that encompass entire populations. The Nordic countries are in the forefront in developing and implementing strategies and specific projects that improve the competitiveness of European clinical research.

Conference objectives

The aim of this Nordic Trial Alliance (NTA) conference is to showcase the opportunities, possibilities and advantages that exist in the Nordic region for clinical research. Each country will present strategies and initiatives from the government level, specific projects undertaken at hospitals and universities, and distinctive resources and platforms for clinical research.

Who should attend?

The main audience is researchers, authorities and regulators, ethical committees, politicians, patient organizations, clinical research and development directors and managers from Nordic pharmaceutical companies.

Registration and cancellations

The last official registration date is April 8th. When registering, please inform us which conference day or days you are attending. 

Cancellations can be made at no charge up until 14 days before the conference. Registrations cancelled less than 14 days before the conference will be charged 100 €/conference day (+ VAT 24 %) of the cancellation charges and organization costs. Cancellations should be addressed in writing. 

Exhibition area

We offer organizations an exhibition package for 500 € (+ VAT 24 %) for PIF, LIF and LMI member companies and 700 € (+ VAT 24 %) for non-members. All stands come equipped with a power socket, a table and a place for company's own roll up. The fee also includes a complimentary registration for one company representative, including lunch and refreshments during the conference days.

Please contact koulutus@laaketietokeskus.fi to book an exhibition package at least 14 days before the conference.

Organizers 

  • Nordic Trial Alliance
  • Norden NordFosk
  • PIF – Pharma Industry Finland
  • LMI – The Association of Pharmaceutical Industry in Norway
  • LIF – The research-based pharmaceutical industry in Sweden
  • LIF – The Danish Association of the Pharmaceutical Industry

Hotels closest to the venue

Crowne Plaza Helsinki (Address: Mannerheimintie 50)

Scandic Park Helsinki (Address: Mannerheimintie 46)

Contact information

For further questions about the conference program, please contact Mia Bengtström, mia.bengtstrom@pif.fi.

For further questions about the registration and the arrangements, please contact koulutus@laaketietokeskus.fi or Viktoria Paananen, viktoria.paananen@laaketietokeskus.fi.

Nordic Trial Alliance – Collaboration between Industry and Academy. Excellent opportunities and possibilities for clinical research in the Nordic region.

The Nordic countries are known for good clinical research, high clinical expertise, excellent opportunities to create advanced research infrastructures, and also for well-organized health care systems that encompass entire populations. The Nordic countries are in the forefront in developing and implementing strategies and specific projects that improve the competitiveness of European clinical research.

The Nordic region constitutes a population of approximately 25 million people, in five countries with similar legal and healthcare systems. The region holds great potential for clinical research, both from an academic and an industry perspective. Recently, many stakeholders, including government agencies, hospitals and academic institutions have expressed concerns, ambitions and initiatives in order to reverse the declining trend in the number of clinical trials and to attract clinical research into the Nordic region.

 

DAY 1: April 22nd 2015

Initiatives to increase clinical research in the Nordics – what can we offer?

11.30 Registration & light lunch (poster set-up)
  Chair: Professor Kalervo Väänänen, Director, University of Turku
12.45 Welcome to conference – overview of the NTA project and aims of the conference
Mia Bengtström, Senior Advisor, Pharma Industry Finland, NTA Board
13.00 Academic Medical Center Helsinki – the host
Professor Risto Renkonen, Dean of the Faculty of Medicine, University of Helsinki, Finland
  Presentation of unique opportunities for research in the Nordic region
13.15 Clinical research in the Nordic countries – from a Pharmaceutical industry perspective – drivers and critical factors involved in decision making for clinical research – how attractive is the Nordic region?
Dr Hassan Ansari, Associate VP & Head of Global Clinical Trials Operations, Europe, MSD (Merck & Co.)
13.45 When an entire country is a cohort
Professor Mads Melbye, Executive Vice President, Statens Serum Institut, Copenhagen, Denmark
14.15 A unique cluster of oncology expertise and innovation
Professor Stener Kvinnsland, Chief Executive Officer of Haukeland University Hospital Norway
14.40 Coffee break and networking , exhibition and poster session 
15.10 Comprehensive Cancer Center Helsinki, a good start for a national CCC and Nordic collaboration
Professor Petri Bono, HUCH Comprehensive Cancer Center, Finland
  Presentation of national governmental initiatives from each Nordic country
Chair: Dr Petri Lehto, Director, Policy and Communication, MSD Finland
15.30 Denmark: National Action Plan for strengthening Public-Private Collaboration on clinical research
Gertrud Rex Baungaard, Head of section, Centre for Hospital Policy, The Danish Ministry of Health
15.50 Finland: Health Sector Growth Strategy for Research and Innovation Activities
Liisa-Maria Voipio-Pulkki, Director, Ministry of Social Affairs and Health
16.10 New ways for industry and academia to start cooperation in a University hospital setting
Professor Pétur Sigurður Gunnarsson, National University Hospital of Iceland
16.30 Sweden: "Strong together" (Starka tillsammans)
Ingrid Petersson, Director General at the Swedish Reseach Council “Formas”, Sweden
16.50 The Norwegian Health&Care21 strategy and clinical trials
Maiken Engelstad, Director at the Ministry of Health and Care Services
17.10 Panel discussion – Are there common grounds for Nordic collaboration within clinical research?
18.00 – Networking and “Food for Thought and Stomach”
 

DAY 2: April 23rd 2015

Health registries and biobanks – Excellent opportunities for clinical research and real-life evaluation

8.00 Registration & Welcome coffee
  Chair: Professor Aarno Palotie, Broad institute, Boston and University of Helsinki – FIMM Finland
9.00 Introduction Health registries and Biobanks – Excellent opportunities for the Nordic countries
Professor Aarno Palotie, Broad Institute/ University of Helsinki – FIMM, Finland
9.20 Electronic health records, medical quality registries and public health registries – is there an opening for connection of data?
PhD Gun Peggy Knudsen, Director, Department of Biobank and Infrastructure, Norwegian Institute of Public Health
9.50 Hospital Biobanks – Use of Specimens and Clinical Information in Building an Innovation Platform
Professor Olli Carpén, University of Turku, Finland
10.20 National hematology biobank and functional drug testing of patient-derived cancer cells
Professor Olli Kallioniemi, University of Helsinki – FIMM, Finland
10.50 Discussion
11.00 Trials of the Future (incl. Discussion)
Dr Andy N. Brown, Global Program Head, Trials of The Future, Novartis Pharma AG
11.35 Lunch Break and networking, exhibition and poster session
12.50 Registry-based randomized trials – the next disruptive technology in clinical research?
Ass. Professor Jonas Oldgren, Executive Director, Uppsala Clinical Research Center, Sweden
13.20 NEXT – National Experimental Therapy Partnership (Denmark as a preferred country for early clinical trials in patients)
Britta Smedegaard Andersen, Project Director, Next, Denmark
13.50 Discussion
14.00 Nordic network for pediatric research
Pirkko Lepola, FinPedMed and project leader NTA pediatrics, Finland
14.20 Pediatric research an excellent opportunity for the Nordic region
Charles A. Thompson, Global Lead for the Pfizer Pediatric Center of Excellence, New York, US
14.50 Discussion
15.05   Next steps and goodbye
Mia Bengtström, Senior Advisor, Pharma Industry Finland, NTA Board 
15.40 – Buss to Airport
Sitemap:

Sivusto ei ole optimoitu IE6-selaimelle

Päivittämällä selaimesi uudempaan versioon:

  • Varmistat uudempaa tekniikkaa sisältävien sivustojen näkymisen oikein
  • Lisäät verkkoturvallisuutta
  • Saat vakaammin toimivan selainympäristön

Päivitä uuteen Internet Explorer -versioon

Päivitä selaimesi alla olevasta olevasta linkistä uusimpaan Internet Explorer -versioon. Internet Explorer on ilmainen ja se on vapaasti ladattavissa Microsoftin sivustolta.

Asenna Firefox

Voit vaihtoehtoisesti siirtyä kokonaan uuteen selaimeen, Firefoxiin. Selain on ilmainen ja se on vapaasti ladattavissa Mozillan sivustolta.

Sulje